These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11064297)

  • 1. Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigators.
    Chang WC; Fu Y; Ohman EM; Gupta M; Morris A; Roth SN; Granger CB; Califf RM; Topol EJ; Mark DB; Armstrong PW
    Can J Cardiol; 2000 Oct; 16(10):1231-9. PubMed ID: 11064297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I.
    Kaul P; Armstrong PW; Chang WC; Naylor CD; Granger CB; Lee KL; Peterson ED; Califf RM; Topol EJ; Mark DB
    Circulation; 2004 Sep; 110(13):1754-60. PubMed ID: 15381645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries.
    Cox JL; Lee E; Langer A; Armstrong PW; Naylor CD
    CMAJ; 1997 Feb; 156(4):497-505. PubMed ID: 9054819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of different patterns of invasive care on quality of life outcomes in patients with non-ST elevation acute coronary syndrome: results from the GUSTO-IIb Canada-United States substudy.
    Kaul P; Armstrong PW; Fu Y; Knight JD; Clapp-Channing NE; Sutherland W; Granger CB; Mark DB;
    Can J Cardiol; 2004 Jun; 20(8):760-6. PubMed ID: 15229756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Pilote L; Califf RM; Sapp S; Miller DP; Mark DB; Weaver WD; Gore JM; Armstrong PW; Ohman EM; Topol EJ
    N Engl J Med; 1995 Aug; 333(9):565-72. PubMed ID: 7623907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial: one-year follow-up of patients without ST-segment elevation. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) II Investigators.
    Fu Y; Chang WC; Mark D; Califf RM; Mackenzie B; Granger CB; Topol EJ; Hlatky M; Armstrong PW
    Circulation; 2000 Sep; 102(12):1375-81. PubMed ID: 10993855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
    Tricoci P; Lokhnygina Y; Berdan LG; Steinhubl SR; Gulba DC; White HD; Kleiman NS; Aylward PE; Langer A; Califf RM; Ferguson JJ; Antman EM; Newby LK; Harrington RA; Goodman SG; Mahaffey KW
    Circulation; 2007 Dec; 116(23):2669-77. PubMed ID: 18025532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials.
    Hudson MP; Granger CB; Topol EJ; Pieper KS; Armstrong PW; Barbash GI; Guerci AD; Vahanian A; Califf RM; Ohman EM
    Circulation; 2001 Sep; 104(11):1229-35. PubMed ID: 11551872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of bleeding academic research consortium (BARC)-defined bleeding complications in ST-segment elevation myocardial infarction: a comparison with the TIMI (Thrombolysis In Myocardial Infarction), GUSTO (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries), and ISTH (International Society on Thrombosis and Haemostasis) bleeding classifications.
    Kikkert WJ; van Geloven N; van der Laan MH; Vis MM; Baan J; Koch KT; Peters RJ; de Winter RJ; Piek JJ; Tijssen JG; Henriques JP
    J Am Coll Cardiol; 2014 May; 63(18):1866-75. PubMed ID: 24657697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial.
    Simes RJ; O'Connell RL; Aylward PE; Varshavsky S; Diaz R; Wilcox RG; Armstrong PW; Granger CB; French JK; Van de Werf F; Marschner IC; Califf R; White HD;
    Am Heart J; 2010 Jun; 159(6):988-97. PubMed ID: 20569711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Van de Werf F; Topol EJ; Lee KL; Woodlief LH; Granger CB; Armstrong PW; Barbash GI; Hampton JR; Guerci A; Simes RJ
    JAMA; 1995 May 24-31; 273(20):1586-91. PubMed ID: 7745771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (gusto I) and assessment of the safety of a new thrombolytic (assent 2) studies.
    Barbash GI; Birnbaum Y; Bogaerts K; Hudson M; Lesaffre E; Fu Y; Goodman S; Houbracken K; Munsters K; Granger CB; Pieper K; Califf RM; Topol EJ; Van De Werf F
    Circulation; 2001 Feb; 103(7):954-60. PubMed ID: 11181469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there evidence of implicit exclusion criteria for elderly subjects in randomized trials? Evidence from the GUSTO-1 study.
    Krumholz HM; Gross CP; Peterson ED; Barron HV; Radford MJ; Parsons LS; Every NR
    Am Heart J; 2003 Nov; 146(5):839-47. PubMed ID: 14597933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials.
    Hasdai D; Topol EJ; Kilaru R; Battler A; Harrington RA; Vahanian A; Ohman EM; Granger CB; Van de Werf F; Simoons ML; O'connor CM; Holmes DR
    Am Heart J; 2003 Jan; 145(1):73-9. PubMed ID: 12514657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
    Hathaway WR; Peterson ED; Wagner GS; Granger CB; Zabel KM; Pieper KS; Clark KA; Woodlief LH; Califf RM
    JAMA; 1998 Feb; 279(5):387-91. PubMed ID: 9459474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of progress in cardiogenic shock: lessons from the GUSTO trials.
    Menon V; Hochman JS; Stebbins A; Pfisterer M; Col J; Anderson RD; Hasdai D; Holmes DR; Bates ER; Topol EJ; Califf RM; Ohman EM
    Eur Heart J; 2000 Dec; 21(23):1928-36. PubMed ID: 11071798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006.
    Rogers WJ; Frederick PD; Stoehr E; Canto JG; Ornato JP; Gibson CM; Pollack CV; Gore JM; Chandra-Strobos N; Peterson ED; French WJ
    Am Heart J; 2008 Dec; 156(6):1026-34. PubMed ID: 19032996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States.
    Mark DB; Naylor CD; Hlatky MA; Califf RM; Topol EJ; Granger CB; Knight JD; Nelson CL; Lee KL; Clapp-Channing NE
    N Engl J Med; 1994 Oct; 331(17):1130-5. PubMed ID: 7935638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary revascularization surgery after myocardial infarction: impact of bypass surgery on survival after thrombolysis. GUSTO Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Tardiff BE; Califf RM; Morris D; Bates E; Woodlief LH; Lee KL; Green C; Rutsch W; Betriu A; Aylward PE; Topol EJ
    J Am Coll Cardiol; 1997 Feb; 29(2):240-9. PubMed ID: 9014973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher rates of coronary angiography and revascularization following myocardial infarction may be associated with greater survival in the United States than in Canada. The CARS Investigators (Coumadin/Aspirin Reinfarction Study).
    Langer A; Fisher M; Califf RM; Goodman S; O'Connor CM; Harrington RA; Fuster V
    Can J Cardiol; 1999 Oct; 15(10):1095-102. PubMed ID: 10523476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.